These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28035072)

  • 21. RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
    Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
    Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
    Iaccarino L; Divona M; Ottone T; Cicconi L; Lavorgna S; Ciardi C; Alfonso V; Travaglini S; Facchini L; Cimino G; Di Bona E; Voso MT; Lo-Coco F
    Genes Chromosomes Cancer; 2019 Jan; 58(1):60-65. PubMed ID: 30421475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
    Zhu G
    Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche.
    Guarnerio J; Mendez LM; Asada N; Menon AV; Fung J; Berry K; Frenette PS; Ito K; Pandolfi PP
    Nat Commun; 2018 Jan; 9(1):66. PubMed ID: 29302031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
    Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
    Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
    Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
    Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eya2, a Target Activated by Plzf, Is Critical for
    Ono R; Masuya M; Ishii S; Katayama N; Nosaka T
    Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.
    Lehmann-Che J; Bally C; Letouzé E; Berthier C; Yuan H; Jollivet F; Ades L; Cassinat B; Hirsch P; Pigneux A; Mozziconacci MJ; Kogan S; Fenaux P; de Thé H
    Nat Commun; 2018 May; 9(1):2047. PubMed ID: 29795382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.
    Truong BT; Lee YJ; Lodie TA; Park DJ; Perrotti D; Watanabe N; Koeffler HP; Nakajima H; Tenen DG; Kogan SC
    Blood; 2003 Feb; 101(3):1141-8. PubMed ID: 12393450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia.
    Kamezaki K; Luchsinger LL; Snoeck HW
    Exp Hematol; 2014 Mar; 42(3):192-203.e1. PubMed ID: 24269847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [hCG-PLZF-RARA transgenic mice develop leukemia resembling human chronic myeloid leukemia].
    Meng X; Cheng G; Wang L
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):22-5. PubMed ID: 11776589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia.
    Tong Q; You H; Chen X; Wang K; Sun W; Pei Y; Zhao X; Yuan M; Zhu H; Luo Z; Zhang Y
    Nucleic Acids Res; 2018 Apr; 46(7):3284-3297. PubMed ID: 29554366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal abnormality of acute promyelocytic leukemia other than
    Imataki O; Uemura M
    BMC Clin Pathol; 2016; 16():16. PubMed ID: 27708545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
    Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
    Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
    J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular biology of acute promyelocytic leukemia.
    Slack JL; Gallagher RE
    Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
    Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.